When could Starliner launch again? NASA, Boeing plan 2026 uncrewed mission

NASA and Boeing are planning an uncrewed Starliner test flight to the ISS as early as April 2026 to validate system upgrades after a failed crewed mission that launched in June 2024 and culminated with astronauts returning on a SpaceX flight in March 2025. NASA and Boeing have restructured their 2014 commercial crew contract, reducing guaranteed Boeing crewed missions from six to four (with two optional), reflecting a delay to certification and potential near-term revenue deferral for Boeing as the company focuses on safety fixes and re‑verification in 2026.

Analysis

Market structure: Boeing (BA) is the clear near-term loser while SpaceX (nonpublic) is the functional winner — NASA will lean more on Dragon, raising SpaceX’s pricing power and utilization for crew/cargo in 2025–26. Prime aerospace suppliers (Lockheed Martin LMT, RTX) are mixed wins: defense revenue stability cushions them versus BA’s program risk. Expect BA equity downside and rising equity implied volatility; BA credit spreads could widen 20–100 bps if market prices program delays/costs into 12–24 month horizons.

Risk assessment: Tail risks include a second Starliner failure (April 2026) triggering contract penalties, congressional oversight, and >$1bn incremental remediation costs — low probability but high impact to BA free cash flow and margins. Immediate (days) risk is sentiment-driven equity moves; short-term (weeks–months) risk is quarterly guidance/contract amendments; long-term (years) risk is market-share loss to SpaceX and potential reduction in NASA guaranteed missions. Hidden dependencies: ULA/partner supply chains and NASA funding cycles; catalysts are NASA reports, congressional hearings, and the April 2026 uncrewed flight.

Trade implications: Near-term defensive stance: hedge or reduce BA equity (2–3% portfolio) and buy protection via 9–12 month put spreads; consider pair trade long LMT (1–2%) vs short BA (1–2%) to capture rotation to steadier defense cashflows. Credit-focused investors should buy 3–5 year BA protection or trim BA bond exposure; avoid naked premium selling on BA — IV likely to spike ahead of April 2026. Entry: act within 2–6 weeks; reassess after Q4 earnings and NASA validation updates in Jan–Mar 2026.

Contrarian angles: Consensus underprices optional upside from a clean April 2026 uncrewed flight — a successful test could re-rate BA by 15–30% over 3–9 months as certification risk falls (historical parallel: post-crisis recoveries like 737 MAX). Conversely, reaction could be overdone if markets assume contract loss; set thresholds: add to long BA only if downside >20% vs peers or if NASA issues a positive validation report by Jan 31, 2026.

Key Decisions for Investors

• Establish a 2–3% portfolio short position on BA using a 9–12 month put spread: buy a 12-month put ~30% OTM and sell a 12-month put ~20% OTM to limit cost; increase hedge to 4% if BA falls >15% within 3 months or if BA CDS widens >50 bps.
• Initiate a relative-value pair trade: go long LMT (Lockheed Martin) equal-dollar 1–2% of portfolio and short BA 1–2% to play rotation into higher-quality defense cashflows; target 6–12 month horizon, take profits if spread widens by >10% relative performance.
• Buy credit protection or reduce corporate-bond exposure: purchase protection on BA 3–5 year tranche (or sell/trim BA corporate bonds by 50%) and set stop-loss if BA bond yield premium over Treasuries narrows by >40 bps or CDS tightens back by >30 bps.
• Event-driven conditional long: if NASA publishes ‘no major anomalies’ in Starliner validation reports by Jan 31, 2026, establish a 1–2% long BA via a Dec-2026 call spread (buy a 12-month ATM call, sell a 12-month 40% OTM call) to capture a potential 15–30% re-rate following a successful April 2026 uncrewed flight.